 | • レポートコード：GIR-107A12140 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、心毒性スクリーニングのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。心毒性スクリーニングの種類別市場規模（試薬、サービス）、用途別市場規模（委託研究機関、製薬会社、学術・研究所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・心毒性スクリーニングの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Admescope Ltd、Stemina Biomarker Discovery、Cyprotex、Eurofins Discovery、Axol Bioscience Ltd、Molecular Devices、AMRI Global、GVK Biosciences、WuXi AppTec、Anbiqi Biotechnology ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：試薬、サービス ・用途別分析2016年-2026年：委託研究機関、製薬会社、学術・研究所、その他 ・心毒性スクリーニングの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・心毒性スクリーニングのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・心毒性スクリーニングのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・心毒性スクリーニングの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・心毒性スクリーニングの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Cardiotoxicity Screening market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Cardiotoxicity Screening size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Cardiotoxicity Screening market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Cardiotoxicity Screening market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Reagent
Service
Market segment by Application, can be divided into
Contract Research Organization
Pharmaceutical Company
Academic and Research Institutes
Others
Market segment by players, this report covers
Admescope Ltd
Stemina Biomarker Discovery
Cyprotex
Eurofins Discovery
Axol Bioscience Ltd
Molecular Devices
AMRI Global
GVK Biosciences
WuXi AppTec
Anbiqi Biotechnology
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Cardiotoxicity Screening product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Cardiotoxicity Screening, with revenue, gross margin and global market share of Cardiotoxicity Screening from 2019 to 2021.
Chapter 3, the Cardiotoxicity Screening competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Cardiotoxicity Screening market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Cardiotoxicity Screening research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Cardiotoxicity Screening
1.2 Classification of Cardiotoxicity Screening by Type
1.2.1 Overview: Global Cardiotoxicity Screening Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Cardiotoxicity Screening Revenue Market Share by Type in 2020
1.2.3 Reagent
1.2.4 Service
1.3 Global Cardiotoxicity Screening Market by Application
1.3.1 Overview: Global Cardiotoxicity Screening Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Contract Research Organization
1.3.3 Pharmaceutical Company
1.3.4 Academic and Research Institutes
1.3.5 Others
1.4 Global Cardiotoxicity Screening Market Size & Forecast
1.5 Global Cardiotoxicity Screening Market Size and Forecast by Region
1.5.1 Global Cardiotoxicity Screening Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Cardiotoxicity Screening Market Size by Region, (2016-2021)
1.5.3 North America Cardiotoxicity Screening Market Size and Prospect (2016-2026)
1.5.4 Europe Cardiotoxicity Screening Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Cardiotoxicity Screening Market Size and Prospect (2016-2026)
1.5.6 South America Cardiotoxicity Screening Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Cardiotoxicity Screening Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Cardiotoxicity Screening Market Drivers
1.6.2 Cardiotoxicity Screening Market Restraints
1.6.3 Cardiotoxicity Screening Trends Analysis
2 Company Profiles
2.1 Admescope Ltd
2.1.1 Admescope Ltd Details
2.1.2 Admescope Ltd Major Business
2.1.3 Admescope Ltd Cardiotoxicity Screening Product and Solutions
2.1.4 Admescope Ltd Cardiotoxicity Screening Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Admescope Ltd Recent Developments and Future Plans
2.2 Stemina Biomarker Discovery
2.2.1 Stemina Biomarker Discovery Details
2.2.2 Stemina Biomarker Discovery Major Business
2.2.3 Stemina Biomarker Discovery Cardiotoxicity Screening Product and Solutions
2.2.4 Stemina Biomarker Discovery Cardiotoxicity Screening Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Stemina Biomarker Discovery Recent Developments and Future Plans
2.3 Cyprotex
2.3.1 Cyprotex Details
2.3.2 Cyprotex Major Business
2.3.3 Cyprotex Cardiotoxicity Screening Product and Solutions
2.3.4 Cyprotex Cardiotoxicity Screening Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Cyprotex Recent Developments and Future Plans
2.4 Eurofins Discovery
2.4.1 Eurofins Discovery Details
2.4.2 Eurofins Discovery Major Business
2.4.3 Eurofins Discovery Cardiotoxicity Screening Product and Solutions
2.4.4 Eurofins Discovery Cardiotoxicity Screening Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Eurofins Discovery Recent Developments and Future Plans
2.5 Axol Bioscience Ltd
2.5.1 Axol Bioscience Ltd Details
2.5.2 Axol Bioscience Ltd Major Business
2.5.3 Axol Bioscience Ltd Cardiotoxicity Screening Product and Solutions
2.5.4 Axol Bioscience Ltd Cardiotoxicity Screening Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Axol Bioscience Ltd Recent Developments and Future Plans
2.6 Molecular Devices
2.6.1 Molecular Devices Details
2.6.2 Molecular Devices Major Business
2.6.3 Molecular Devices Cardiotoxicity Screening Product and Solutions
2.6.4 Molecular Devices Cardiotoxicity Screening Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Molecular Devices Recent Developments and Future Plans
2.7 AMRI Global
2.7.1 AMRI Global Details
2.7.2 AMRI Global Major Business
2.7.3 AMRI Global Cardiotoxicity Screening Product and Solutions
2.7.4 AMRI Global Cardiotoxicity Screening Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 AMRI Global Recent Developments and Future Plans
2.8 GVK Biosciences
2.8.1 GVK Biosciences Details
2.8.2 GVK Biosciences Major Business
2.8.3 GVK Biosciences Cardiotoxicity Screening Product and Solutions
2.8.4 GVK Biosciences Cardiotoxicity Screening Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 GVK Biosciences Recent Developments and Future Plans
2.9 WuXi AppTec
2.9.1 WuXi AppTec Details
2.9.2 WuXi AppTec Major Business
2.9.3 WuXi AppTec Cardiotoxicity Screening Product and Solutions
2.9.4 WuXi AppTec Cardiotoxicity Screening Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 WuXi AppTec Recent Developments and Future Plans
2.10 Anbiqi Biotechnology
2.10.1 Anbiqi Biotechnology Details
2.10.2 Anbiqi Biotechnology Major Business
2.10.3 Anbiqi Biotechnology Cardiotoxicity Screening Product and Solutions
2.10.4 Anbiqi Biotechnology Cardiotoxicity Screening Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Anbiqi Biotechnology Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Cardiotoxicity Screening Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Cardiotoxicity Screening Players Market Share
3.2.2 Top 10 Cardiotoxicity Screening Players Market Share
3.2.3 Market Competition Trend
3.3 Cardiotoxicity Screening Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Cardiotoxicity Screening Revenue and Market Share by Type (2016-2021)
4.2 Global Cardiotoxicity Screening Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Cardiotoxicity Screening Revenue Market Share by Application (2016-2021)
5.2 Cardiotoxicity Screening Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Cardiotoxicity Screening Revenue by Type (2016-2026)
6.2 North America Cardiotoxicity Screening Revenue by Application (2016-2026)
6.3 North America Cardiotoxicity Screening Market Size by Country
6.3.1 North America Cardiotoxicity Screening Revenue by Country (2016-2026)
6.3.2 United States Cardiotoxicity Screening Market Size and Forecast (2016-2026)
6.3.3 Canada Cardiotoxicity Screening Market Size and Forecast (2016-2026)
6.3.4 Mexico Cardiotoxicity Screening Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Cardiotoxicity Screening Revenue by Type (2016-2026)
7.2 Europe Cardiotoxicity Screening Revenue by Application (2016-2026)
7.3 Europe Cardiotoxicity Screening Market Size by Country
7.3.1 Europe Cardiotoxicity Screening Revenue by Country (2016-2026)
7.3.2 Germany Cardiotoxicity Screening Market Size and Forecast (2016-2026)
7.3.3 France Cardiotoxicity Screening Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Cardiotoxicity Screening Market Size and Forecast (2016-2026)
7.3.5 Russia Cardiotoxicity Screening Market Size and Forecast (2016-2026)
7.3.6 Italy Cardiotoxicity Screening Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Cardiotoxicity Screening Revenue by Type (2016-2026)
8.2 Asia-Pacific Cardiotoxicity Screening Revenue by Application (2016-2026)
8.3 Asia-Pacific Cardiotoxicity Screening Market Size by Region
8.3.1 Asia-Pacific Cardiotoxicity Screening Revenue by Region (2016-2026)
8.3.2 China Cardiotoxicity Screening Market Size and Forecast (2016-2026)
8.3.3 Japan Cardiotoxicity Screening Market Size and Forecast (2016-2026)
8.3.4 South Korea Cardiotoxicity Screening Market Size and Forecast (2016-2026)
8.3.5 India Cardiotoxicity Screening Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Cardiotoxicity Screening Market Size and Forecast (2016-2026)
8.3.7 Australia Cardiotoxicity Screening Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Cardiotoxicity Screening Revenue by Type (2016-2026)
9.2 South America Cardiotoxicity Screening Revenue by Application (2016-2026)
9.3 South America Cardiotoxicity Screening Market Size by Country
9.3.1 South America Cardiotoxicity Screening Revenue by Country (2016-2026)
9.3.2 Brazil Cardiotoxicity Screening Market Size and Forecast (2016-2026)
9.3.3 Argentina Cardiotoxicity Screening Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Cardiotoxicity Screening Revenue by Type (2016-2026)
10.2 Middle East & Africa Cardiotoxicity Screening Revenue by Application (2016-2026)
10.3 Middle East & Africa Cardiotoxicity Screening Market Size by Country
10.3.1 Middle East & Africa Cardiotoxicity Screening Revenue by Country (2016-2026)
10.3.2 Turkey Cardiotoxicity Screening Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Cardiotoxicity Screening Market Size and Forecast (2016-2026)
10.3.4 UAE Cardiotoxicity Screening Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Cardiotoxicity Screening Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Cardiotoxicity Screening Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Cardiotoxicity Screening Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Cardiotoxicity Screening Revenue (USD Million) by Region (2016-2021)
Table 5. Global Cardiotoxicity Screening Revenue Market Share by Region (2021-2026)
Table 6. Admescope Ltd Corporate Information, Head Office, and Major Competitors
Table 7. Admescope Ltd Major Business
Table 8. Admescope Ltd Cardiotoxicity Screening Product and Solutions
Table 9. Admescope Ltd Cardiotoxicity Screening Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Stemina Biomarker Discovery Corporate Information, Head Office, and Major Competitors
Table 11. Stemina Biomarker Discovery Major Business
Table 12. Stemina Biomarker Discovery Cardiotoxicity Screening Product and Solutions
Table 13. Stemina Biomarker Discovery Cardiotoxicity Screening Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Cyprotex Corporate Information, Head Office, and Major Competitors
Table 15. Cyprotex Major Business
Table 16. Cyprotex Cardiotoxicity Screening Product and Solutions
Table 17. Cyprotex Cardiotoxicity Screening Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Eurofins Discovery Corporate Information, Head Office, and Major Competitors
Table 19. Eurofins Discovery Major Business
Table 20. Eurofins Discovery Cardiotoxicity Screening Product and Solutions
Table 21. Eurofins Discovery Cardiotoxicity Screening Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Axol Bioscience Ltd Corporate Information, Head Office, and Major Competitors
Table 23. Axol Bioscience Ltd Major Business
Table 24. Axol Bioscience Ltd Cardiotoxicity Screening Product and Solutions
Table 25. Axol Bioscience Ltd Cardiotoxicity Screening Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Molecular Devices Corporate Information, Head Office, and Major Competitors
Table 27. Molecular Devices Major Business
Table 28. Molecular Devices Cardiotoxicity Screening Product and Solutions
Table 29. Molecular Devices Cardiotoxicity Screening Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. AMRI Global Corporate Information, Head Office, and Major Competitors
Table 31. AMRI Global Major Business
Table 32. AMRI Global Cardiotoxicity Screening Product and Solutions
Table 33. AMRI Global Cardiotoxicity Screening Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. GVK Biosciences Corporate Information, Head Office, and Major Competitors
Table 35. GVK Biosciences Major Business
Table 36. GVK Biosciences Cardiotoxicity Screening Product and Solutions
Table 37. GVK Biosciences Cardiotoxicity Screening Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. WuXi AppTec Corporate Information, Head Office, and Major Competitors
Table 39. WuXi AppTec Major Business
Table 40. WuXi AppTec Cardiotoxicity Screening Product and Solutions
Table 41. WuXi AppTec Cardiotoxicity Screening Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Anbiqi Biotechnology Corporate Information, Head Office, and Major Competitors
Table 43. Anbiqi Biotechnology Major Business
Table 44. Anbiqi Biotechnology Cardiotoxicity Screening Product and Solutions
Table 45. Anbiqi Biotechnology Cardiotoxicity Screening Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Cardiotoxicity Screening Revenue (USD Million) by Players (2019-2021)
Table 47. Global Cardiotoxicity Screening Revenue Share by Players (2019-2021)
Table 48. Breakdown of Cardiotoxicity Screening by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Cardiotoxicity Screening Players Head Office, Products and Services Provided
Table 50. Cardiotoxicity Screening Mergers & Acquisitions in the Past Five Years
Table 51. Cardiotoxicity Screening New Entrants and Expansion Plans
Table 52. Global Cardiotoxicity Screening Revenue (USD Million) by Type (2016-2021)
Table 53. Global Cardiotoxicity Screening Revenue Share by Type (2016-2021)
Table 54. Global Cardiotoxicity Screening Revenue Forecast by Type (2021-2026)
Table 55. Global Cardiotoxicity Screening Revenue by Application (2016-2021)
Table 56. Global Cardiotoxicity Screening Revenue Forecast by Application (2021-2026)
Table 57. North America Cardiotoxicity Screening Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Cardiotoxicity Screening Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Cardiotoxicity Screening Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Cardiotoxicity Screening Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Cardiotoxicity Screening Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Cardiotoxicity Screening Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Cardiotoxicity Screening Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Cardiotoxicity Screening Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Cardiotoxicity Screening Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Cardiotoxicity Screening Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Cardiotoxicity Screening Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Cardiotoxicity Screening Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Cardiotoxicity Screening Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Cardiotoxicity Screening Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Cardiotoxicity Screening Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Cardiotoxicity Screening Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Cardiotoxicity Screening Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Cardiotoxicity Screening Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Cardiotoxicity Screening Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Cardiotoxicity Screening Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Cardiotoxicity Screening Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Cardiotoxicity Screening Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Cardiotoxicity Screening Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Cardiotoxicity Screening Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Cardiotoxicity Screening Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Cardiotoxicity Screening Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Cardiotoxicity Screening Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Cardiotoxicity Screening Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Cardiotoxicity Screening Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Cardiotoxicity Screening Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Cardiotoxicity Screening Picture
Figure 2. Global Cardiotoxicity Screening Revenue Market Share by Type in 2020
Figure 3. Reagent
Figure 4. Service
Figure 5. Cardiotoxicity Screening Revenue Market Share by Application in 2020
Figure 6. Contract Research Organization Picture
Figure 7. Pharmaceutical Company Picture
Figure 8. Academic and Research Institutes Picture
Figure 9. Others Picture
Figure 10. Global Cardiotoxicity Screening Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Cardiotoxicity Screening Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Cardiotoxicity Screening Revenue Market Share by Region (2016-2026)
Figure 13. Global Cardiotoxicity Screening Revenue Market Share by Region in 2020
Figure 14. North America Cardiotoxicity Screening Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Cardiotoxicity Screening Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Cardiotoxicity Screening Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Cardiotoxicity Screening Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Cardiotoxicity Screening Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Cardiotoxicity Screening Market Drivers
Figure 20. Cardiotoxicity Screening Market Restraints
Figure 21. Cardiotoxicity Screening Market Trends
Figure 22. Admescope Ltd Recent Developments and Future Plans
Figure 23. Stemina Biomarker Discovery Recent Developments and Future Plans
Figure 24. Cyprotex Recent Developments and Future Plans
Figure 25. Eurofins Discovery Recent Developments and Future Plans
Figure 26. Axol Bioscience Ltd Recent Developments and Future Plans
Figure 27. Molecular Devices Recent Developments and Future Plans
Figure 28. AMRI Global Recent Developments and Future Plans
Figure 29. GVK Biosciences Recent Developments and Future Plans
Figure 30. WuXi AppTec Recent Developments and Future Plans
Figure 31. Anbiqi Biotechnology Recent Developments and Future Plans
Figure 32. Global Cardiotoxicity Screening Revenue Share by Players in 2020
Figure 33. Cardiotoxicity Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 34. Global Top 3 Players Cardiotoxicity Screening Revenue Market Share in 2020
Figure 35. Global Top 10 Players Cardiotoxicity Screening Revenue Market Share in 2020
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 37. Global Cardiotoxicity Screening Revenue Share by Type in 2020
Figure 38. Global Cardiotoxicity Screening Market Share Forecast by Type (2021-2026)
Figure 39. Global Cardiotoxicity Screening Revenue Share by Application in 2020
Figure 40. Global Cardiotoxicity Screening Market Share Forecast by Application (2021-2026)
Figure 41. North America Cardiotoxicity Screening Sales Market Share by Type (2016-2026)
Figure 42. North America Cardiotoxicity Screening Sales Market Share by Application (2016-2026)
Figure 43. North America Cardiotoxicity Screening Revenue Market Share by Country (2016-2026)
Figure 44. United States Cardiotoxicity Screening Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Cardiotoxicity Screening Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Cardiotoxicity Screening Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Cardiotoxicity Screening Sales Market Share by Type (2016-2026)
Figure 48. Europe Cardiotoxicity Screening Sales Market Share by Application (2016-2026)
Figure 49. Europe Cardiotoxicity Screening Revenue Market Share by Country (2016-2026)
Figure 50. Germany Cardiotoxicity Screening Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Cardiotoxicity Screening Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Cardiotoxicity Screening Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Cardiotoxicity Screening Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Cardiotoxicity Screening Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Cardiotoxicity Screening Sales Market Share by Type (2016-2026)
Figure 56. Asia-Pacific Cardiotoxicity Screening Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Cardiotoxicity Screening Revenue Market Share by Region (2016-2026)
Figure 58. China Cardiotoxicity Screening Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Cardiotoxicity Screening Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South Korea Cardiotoxicity Screening Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Cardiotoxicity Screening Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Cardiotoxicity Screening Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Cardiotoxicity Screening Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Cardiotoxicity Screening Sales Market Share by Type (2016-2026)
Figure 65. South America Cardiotoxicity Screening Sales Market Share by Application (2016-2026)
Figure 66. South America Cardiotoxicity Screening Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Cardiotoxicity Screening Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Cardiotoxicity Screening Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East and Africa Cardiotoxicity Screening Sales Market Share by Type (2016-2026)
Figure 70. Middle East and Africa Cardiotoxicity Screening Sales Market Share by Application (2016-2026)
Figure 71. Middle East and Africa Cardiotoxicity Screening Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Cardiotoxicity Screening Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Cardiotoxicity Screening Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. UAE Cardiotoxicity Screening Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界の出生前検査・新生児スクリーニング市場 2021：企業別、地域別、種類・用途別 The Prenatal Testing and Newborn Screening market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…- 世界の廃水スクリーニング装置市場 2021：企業別、地域別、種類・用途別 The Wastewater Screening Equipment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 世界の家庭用睡眠スクリーニング装置市場 2021：企業別、地域別、種類・用途別 The Home Sleep Screening Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 世界の出生前検査及び新生児スクリーニング市場予測（～2024年） Prenatal testing is performed on the mother during pregnancy. Newborn screening is performed after the baby is born. Scope of the Report: The global Prenatal Testing and Newborn Screening market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing a…
- 非侵襲的非経口スクリーニングの世界市場 2019年版：種類別（装置、消耗品）、用途別（診断研究所、病院） Scope of the Report: The global Non-invasive Parenteral Screening market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially i…